Growth Metrics

Insight Molecular Diagnostics (IMDX) Non-Current Deferred Tax Liability (2020 - 2023)

Insight Molecular Diagnostics (IMDX) has disclosed Non-Current Deferred Tax Liability for 2 consecutive years, with $2.2 million as the latest value for Q3 2023.